Bio Medica Laboratories Analysis Subscription Profit & Loss Ratios Objects Dates Lot Size Allotment

Bio Medica Laboratories Ltd

·
₹139.00 Issue Price
2026-05-21 – 2026-05-25
biomedica.co.in Mainboard · BSE SME
Open Date
2026-05-21
Close Date
2026-05-25
Listing Date
2026-05-29
Allotment Date
2026-05-26
Current Price
₹139.00
High / Low
₹— / ₹—
ROCE
23.22 %
ROE
54.41 %
Face Value
₹10
Add ratio to table Edit ratios
About
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in …
📍 Plot No. 11B-11C, Sector-E, Sanwer Road Industrial Area, Industrial Estate (Indo…
📞 +91 7314102751
✉️ companysecretary@biomedica.co.in

Analysis

Pros

  • ROE of 54.41%% indicates good return on equity.
  • ROCE of 23.22%% shows efficient capital usage.
  • PAT margin of 30.35%%.

Cons

  • Debt/equity of 2.23x may be high.

Pros and cons are machine generated. Please exercise caution and do your own analysis.

Subscription Status

Consolidated figures
Day 1
0.00×
Day 2
0.00×
Day 3
0.00×
MetricQIBNII (HNI)RetailTotal
Subscription — — — —
Shares 36,000 17,55,000 17,92,000 37,72,000
Bids — — — —
▼ Category-wise Detailed Breakdown
CategorySubscriptionOffered Bid SharesAmt (₹ Cr)
QIB - 36,000 — ₹0.50
NII (HNI) - 17,55,000 — ₹24.39
Retail - 17,92,000 — ₹24.91
Market Maker 1.00×
1,89,000 1,89,000 ₹2.63
Total - 37,72,000 1,89,000 ₹52.43 Cr
Applications: - Total Bid Amount: ₹52.43 Cr

Profit & Loss

Figures in ₹ Crores / Amount in ₹ Crore
Metric 30 Nov 202531 Mar 202531 Mar 2024
Revenue 28.63 38.33 15.34
EBITDA 13.45 15.21 5.63
Profit After Tax 8.66 9.79 2.50
Net Worth 17.12 14.73 4.94
Total Assets 65.17 39.12 19.53
Reserves 7.94 5.55 4.84
Borrowings 38.17 15.01 10.49
Sales Growth
3 Years:-46.4%
Latest:15.34 Cr
Profit Growth
3 Years:-71.1%
Latest PAT:2.50 Cr
Return on Equity
ROE:54.41%%
ROCE:23.22%%

Key Financial Ratios

Profitability
ROE 54.41%%
ROCE 23.22%%
RONW 54.41%%
PAT Margin 30.35%%
EBITDA Margin 47.11%%
Valuation
Pre EPS 10.67
Post EPS 10.33
Pre P/E 13.03×
Post P/E 13.45×
Leverage & Growth
Debt / Equity 2.23×
Sales Growth (3yr) -46.4%
Profit Growth (3yr) -71.1%
Latest Revenue 15.34 Cr
Latest PAT 2.50 Cr

Objects of the Issue

1 Repayment of loan ₹6.50 Cr
2 Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises ₹28.50 Cr
3 General Corporate Purposes

IPO Schedule & Important Dates

IPO Open
2026-05-21
Upcoming
IPO Close
2026-05-25
Upcoming
Allotment
2026-05-26
Upcoming
Refund
2026-05-27
Upcoming
Demat Credit
2026-05-27
Upcoming
Listing
2026-05-29
Upcoming

Lot Size & Investment Details

RETAIL MIN
₹139,000
1 lot · 1000 shares
RETAIL MAX
₹278,000
2 lots · 2,000 shares
HNI MIN
₹417,000
3 lots
Category Lots Shares Amount (₹)
Retail (Min) 1000 1,000 ₹139,000
Retail (Max) 2 2,000 ₹278,000
HNI (Min) 3 3,000 ₹417,000
Pre-Issue Holding: 91,80,001 shares Post-Issue Holding: 1,25,75,001 shares

Lead Managers & Market Makers

Book Running Lead Managers
Narnolia Financial Services Ltd
Market Makers
Prabhat Financial Services Ltd.

Allotment Status

Allotment Date: 2026-05-26
Registrar: Skyline Financial Services Pvt.Ltd
Check Allotment
02228511022
ipo@skylinerta.com
https://www.skylinerta.com/ipo.php